Verification of the IDI-MRSA assay for detecting methicillin-resistant Staphylococcus aureus in diverse specimen types in a core clinical laboratory setting
- PMID: 17021113
- PMCID: PMC1594777
- DOI: 10.1128/JCM.01509-06
Verification of the IDI-MRSA assay for detecting methicillin-resistant Staphylococcus aureus in diverse specimen types in a core clinical laboratory setting
Abstract
The IDI-MRSA assay has a sensitivity of 96% and a specificity of 96% when used to screen patients at extranasal sites. This verification study used previously unverified swabs and was undertaken in a core medical laboratory using nonmicrobiology technologists trained in sample processing, molecular laboratory work flow, and PCR practice.
References
-
- Calfee, D. P., L. J. Durbin, T. P. Germanson, D. M. Toney, E. B. Smith, and B. M. Farr. 2003. Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect. Control Hosp. Epidemiol. 24:422-426. - PubMed
-
- Canadian External Quality Assessment Advisory Group for Antibiotic Resistance. 1998. Guidelines for the testing and reporting of antimicrobial susceptibilities of methicillin-resistant Staphylococcus aureus (MRSA) and commentary on methicillin-resistant coagulase-negative staphylococci (MR-CNS). Canadian External Quality Assessment Advisory Group for Antibiotic Resistance, Ottawa, Ontario, Canada.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
